293780.KQ
AptaBio Therapeutics Inc.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 5,310.00
−3.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.39x
- Price / sales
- 30.07x
- Price / cash flow
- -8.23x
Enterprise value
- Enterprise value
- KRW 132.3B
- EV / sales
- 27.84x
- EV / EBITDA
- -5.79x
- EV / EBIT
- -7.20x
- Market cap
- KRW 142.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026